Results

Total Results: 1,224 records

Showing results for "irritability".

81. Management of Infantile Hemangioma | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/infantile-hemangioma/policymaker
    June 21, 2016 - Clinically important harms of steroids--some of which may be short lived--included Cushingoid facies, irritability

82. Management of Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
    June 01, 2016 - steroids were associated with harms — some of which may be short lived — such as Cushingoid facies, irritability … clinically important adverse effects, including Cushingoid facies, growth retardation, mood changes/ irritability

83. Interview | Digital Healthcare Research
    digital.ahrq.gov/research-method/interview
    January 01, 2022 - Interview Modeling patient-centered medical home principles, attributes, and patient experiences - narrative report Citation Waldren S, Arora D, Brown B, et al. Modeling patient-centered medical home principles, attributes,…

84. 143. Treatment Recommendations: Medications-Nicotine Nasal Spray (cont | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide143.html
    October 01, 2014 - 143. Treatment Recommendations: Medications-Nicotine Nasal Spray (cont Treating Tobacco Use and Dependence: 2008 Update Text version of slide presentation. Dosage A dose of nicotine nasal spray consists of one 0.5 mg dose delivered to each nostril (1 mg total). Initial dosing should be 1-2 doses per hou…

85. 36.92 Handout—NRT & Bupropion combined | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/curriculum/diabnotebk/diabnotebk3692.html
    October 01, 2014 - SHARE: More topics in this section Prevention Chronic Care Clinical Guidelines and Recommendations Clinicians and Providers Curriculum Tools Diabetes Planned Visit Notebook iADAPT Resources Diabetes Planned Visit Notebook 36.92 Handout—NRT & Bupropion combined Previous Page Next Page Table of Contents Diab…

86. Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/clabsi-learning-from-defects.pdf
    April 01, 2022 - Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) AHRQ Safety Progr…

87. Draft Research Plan: Lynch Syndrome-Related Cancer in Adults: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/lynch-syndrome-related-cancer-adults-risk-assessment-genetic-counseling-testing
    February 02, 2023 - Share to Facebook Share to Twitter Share to WhatsApp Share to E-mail Print in progress Draft Research Plan Lynch Syndrome-Related Cancer in Adults: Risk Assessment, Genetic Counseling, and Genetic Testing February 02,…

88. Draft Research Plan: Anal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/anal-cancer-screening
    December 08, 2022 - Share to Facebook Share to Twitter Share to WhatsApp Share to E-mail Print in progress Draft Research Plan Anal Cancer: Screening December 08, 2022 Recommendations made by the USPSTF are independent of the U.S. gove…

89. Module 2: Urinary Catheter Maintenance Facilitator Notes | Agency for Healthcare Research and Quality
    www.ahrq.gov/hai/cauti-tools/facil-guide/preventing-cauti-icu-setting-module2-speaker-notes.html
    February 01, 2023 - Module 2: Urinary Catheter Maintenance Facilitator Notes Preventing CAUTI in the ICU Setting Slide 1 Say: In Module 1, we discussed the indications for an indwelling urinary catheter, the causes of catheter-associated urinary tract infections or CAUTI in the intensive care unit or ICU, as well as metho…

90. Management of Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_policymaker.pdf
    June 01, 2016 - Clinically important harms of steroids—some of which may be short lived—included Cushingoid facies, irritability

91. Preventing-Cauti-Icu-Setting-Module 2-Speaker-Notes (doc file)
    www.ahrq.gov/sites/default/files/wysiwyg/hai/cauti-tools/cauti-icu/preventing-cauti-icu-setting-module_2-speaker-notes.docx
    September 01, 2015 - AHRQ Safety Program for Reducing CAUTI in Hospitals Preventing CAUTI in the ICU Setting Module 2: Urinary Catheter Maintenance SAY: In Module 1, we discussed the indications for an indwelling urinary catheter, the causes of catheter-associated urinary tract infections or CAUTI in the intensive care unit or ICU, as…

92. Appendix G. Safety and Adverse Events | Agency for Healthcare Research and Quality
    www.ahrq.gov/hai/universal-icu-decolonization/universal-icu-apg.html
    September 01, 2013 - Universal ICU Decolonization: An Enhanced Protocol Appendix G. Safety and Adverse Events Previous Page   Table of Contents Universal ICU Decolonization: An Enhanced Protocol Introduction and Welcome Universal ICU Decolonization Protocol Overview Scientific Rationale References Appendix A. …

93. 146. Treatment Recommendations: Medications-Nicotine Patch (continued) | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide146.html
    October 01, 2014 - 146. Treatment Recommendations: Medications-Nicotine Patch (continued) Treating Tobacco Use and Dependence: 2008 Update Text version of slide presentation. Availability OTC or prescription Type Duration Dosage Step-Down Dosage 4 weeks 21 mg/24 hours Step-Down Dosage then 2 weeks 14 mg/…

94. Appendix G. Safety and Adverse Events | Agency for Healthcare Research and Quality
    www.ahrq.gov/es/hai/universal-icu-decolonization/universal-icu-apg.html
    September 01, 2013 - Universal ICU Decolonization: An Enhanced Protocol Appendix G. Safety and Adverse Events Previous Page   Table of Contents Universal ICU Decolonization: An Enhanced Protocol Introduction and Welcome Universal ICU Decolonization Protocol Overview Scientific Rationale References Appendix A. …

95. FAQs (Staff): Nasal Iodophor for MRSA-Positive Patients With Devices (doc file)
    www.ahrq.gov/sites/default/files/wysiwyg/hai/abate/faqs/faq-iodophor.docx
    March 01, 2022 - FAQs (Staff): Nasal Iodophor for MRSA-Positive Patients With Devices Decolonization of Non-ICU Patients With Devices Section 14-3 – Addressing Questions Asked by Staff: Nasal Iodophor for MRSA Carriers With Devices What is iodophor and how safe is it? Iodophor is another name for “povidone-iodine,” which is an o…

96. Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/clabsi-learning-from-defects.pdf
    April 01, 2022 - Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) AHRQ Safety Progr…

97. Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/clabsi-learning-from-defects.pdf
    April 01, 2022 - Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) AHRQ Safety Progr…

98. Untitled (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-medical-update_research-protocol.pdf
    February 16, 2016 - Food and Drug Administration (FDA) for treatment of irritability and challenging behaviors in ASD (Table … b)   What are the effects on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … b)   What are the effects on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability

99. Medical and Sensory-Related Therapies for Children with Autism Spectrum Disorder-An Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/autism-medical-update/research-protocol
    February 16, 2016 - Food and Drug Administration (FDA) for treatment of irritability and challenging behaviors in ASD ( Table … What are the effects on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … What are the effects on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability … longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical, mood/anxiety, irritability

100. Preventing-Cauti-Icu-Setting-Module 2-Speaker-Notes (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/hai/cauti-tools/cauti-icu/preventing-cauti-icu-setting-module_2-speaker-notes.docx
     September 01, 2015 - AHRQ Safety Program for Reducing CAUTI in Hospitals Preventing CAUTI in the ICU Setting Module 2: Urinary Catheter Maintenance SAY: In Module 1, we discussed the indications for an indwelling urinary catheter, the causes of catheter-associated urinary tract infections or CAUTI in the intensive care unit or ICU, as…